Dong-A ST Signs 'Heart Diagnosis Center Operation MOU' with Meju and Kosin University Gospel Hospital

Park Jeonghwan, CEO of Meju, Heo Jeongho, Head of Cardiology at Kosin University Gospel Hospital, Oh Kyungseung, Director of Kosin University Gospel Hospital, and Lee Seonggeun, Executive Director of Dong-A ST (from left), are posing for a commemorative photo at the signing ceremony of the "Business Agreement for the Establishment of the Cardiac Diagnosis Center" held on the 17th. (Photo by Dong-A ST)

[Asia Economy Reporter Chunhee Lee] Dong-A ST announced on the 18th that it signed a "Business Agreement for the Establishment of a Cardiac Diagnosis Center" with Meju and Kosin University Gospel Hospital at Kosin University Gospel Hospital in Seo-gu, Busan on the 17th.

Through this agreement, Dong-A ST, Meju, and Kosin University Gospel Hospital will cooperate to ▲provide cardiac management services based on Mobile Cardiac Telemetry (MCT) ▲establish a cardiac cooperative system with primary and secondary medical institutions in the Busan and Gyeongnam regions centered on the cardiology department of Kosin University Gospel Hospital ▲build a remote electrocardiogram (ECG) reading center.

To this end, Dong-A ST plans to conduct sales and marketing activities targeting primary medical institutions such as clinics and public health centers, as well as secondary medical institutions such as hospitals and general hospitals in the Busan and Gyeongnam regions. The cardiology department of Kosin University Gospel Hospital will introduce Meju’s ECG monitoring platform ‘HiCardi’ to provide cardiac management services to visiting patients, establish a cooperative system with primary and secondary medical institutions in the Busan and Gyeongnam regions, and expand services. Meju will be responsible for technical support of HiCardi.

HiCardi, the remote ECG monitoring platform developed by Meju, uses wearable patches and smartphones to monitor multiple patients’ ECG, heart rate, body surface temperature, and respiration in real time anytime and anywhere, thereby improving the diagnostic rate of heart diseases. Since participating as a strategic investor in Meju in November last year, Dong-A ST has been seeking synergy between Meju’s real-time heart disease monitoring technology and Dong-A ST’s specialty pharmaceuticals and medical device/diagnostic business.

Seonggeun Lee, Executive Director of Dong-A ST, said, “Through this agreement, we hope to provide high-quality medical services to patients and create an environment where they can receive treatment conveniently, contributing to improving patients’ quality of life,” adding, “Dong-A ST will also do its best to help the remote ECG reading center take root in Korea.”

This content was produced with the assistance of AI translation services.